103 related articles for article (PubMed ID: 16709188)
1. Interferon and heparan sulphate.
Lortat-Jacob H
Biochem Soc Trans; 2006 Jun; 34(Pt 3):461-4. PubMed ID: 16709188
[TBL] [Abstract][Full Text] [Related]
2. Heparan sulfate mimicry: a synthetic glycoconjugate that recognizes the heparin binding domain of interferon-gamma inhibits the cytokine activity.
Sarrazin S; Bonnaffé D; Lubineau A; Lortat-Jacob H
J Biol Chem; 2005 Nov; 280(45):37558-64. PubMed ID: 16155294
[TBL] [Abstract][Full Text] [Related]
3. Molecular organization of the interferon gamma-binding domain in heparan sulphate.
Lortat-Jacob H; Turnbull JE; Grimaud JA
Biochem J; 1995 Sep; 310 ( Pt 2)(Pt 2):497-505. PubMed ID: 7654188
[TBL] [Abstract][Full Text] [Related]
4. Non-receptor-mediated tissue localization of human interferon-gamma: role of heparan sulfate/heparin-like molecules.
Lortat-Jacob H; Brisson C; Guerret S; Morel G
Cytokine; 1996 Jul; 8(7):557-66. PubMed ID: 8891437
[TBL] [Abstract][Full Text] [Related]
5. The heparan sulfate binding sequence of interferon-gamma increased the on rate of the interferon-gamma-interferon-gamma receptor complex formation.
Sadir R; Forest E; Lortat-Jacob H
J Biol Chem; 1998 May; 273(18):10919-25. PubMed ID: 9556569
[TBL] [Abstract][Full Text] [Related]
6. Gamma interferon signaling: insights to development of interferon mimetics.
Johnson HM; Ahmed CM
Cell Mol Biol (Noisy-le-grand); 2006 May; 52(1):71-6. PubMed ID: 16914098
[TBL] [Abstract][Full Text] [Related]
7. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R
Clin Ter; 2006; 157(4):377-86. PubMed ID: 17051976
[TBL] [Abstract][Full Text] [Related]
8. Endothelial inflammation: the role of differential expression of N-deacetylase/N-sulphotransferase enzymes in alteration of the immunological properties of heparan sulphate.
Carter NM; Ali S; Kirby JA
J Cell Sci; 2003 Sep; 116(Pt 17):3591-600. PubMed ID: 12876215
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of tailor-made glycoconjugate mimetics of heparan sulfate that bind IFN-gamma in the nanomolar range.
Lubineau A; Lortat-Jacob H; Gavard O; Sarrazin S; Bonnaffé D
Chemistry; 2004 Sep; 10(17):4265-82. PubMed ID: 15352109
[TBL] [Abstract][Full Text] [Related]
10. Structural analysis of IL-10 and Type I interferon family members and their complexes with receptor.
Walter MR
Adv Protein Chem; 2004; 68():171-223. PubMed ID: 15500862
[No Abstract] [Full Text] [Related]
11. Binding of endostatin to endothelial heparan sulphate shows a differential requirement for specific sulphates.
Blackhall FH; Merry CL; Lyon M; Jayson GC; Folkman J; Javaherian K; Gallagher JT
Biochem J; 2003 Oct; 375(Pt 1):131-9. PubMed ID: 12812520
[TBL] [Abstract][Full Text] [Related]
12. Multiprotein signalling complexes: regional assembly on heparan sulphate.
Gallagher JT
Biochem Soc Trans; 2006 Jun; 34(Pt 3):438-41. PubMed ID: 16709181
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the recognition of tumor cells by the natural cytotoxicity receptor, NKp44.
Hershkovitz O; Jivov S; Bloushtain N; Zilka A; Landau G; Bar-Ilan A; Lichtenstein RG; Campbell KS; van Kuppevelt TH; Porgador A
Biochemistry; 2007 Jun; 46(25):7426-36. PubMed ID: 17536787
[TBL] [Abstract][Full Text] [Related]
14. Bovine lactoferrin inhibits Japanese encephalitis virus by binding to heparan sulfate and receptor for low density lipoprotein.
Chien YJ; Chen WJ; Hsu WL; Chiou SS
Virology; 2008 Sep; 379(1):143-51. PubMed ID: 18640695
[TBL] [Abstract][Full Text] [Related]
15. Interferon-gamma C-terminal function: new working hypothesis. Heparan sulfate and heparin, new targets for IFN-gamma, protect, relax the cytokine and regulate its activity.
Lortat-Jacob H; Grimaud JA
Cell Mol Biol; 1991; 37(3):253-60. PubMed ID: 1934005
[TBL] [Abstract][Full Text] [Related]
16. The role of heparin/heparan sulphate in the IFN-γ-led Arena.
Xu K; Jin L
Biochimie; 2020 Mar; 170():1-9. PubMed ID: 31794784
[TBL] [Abstract][Full Text] [Related]
17. Sleep and body temperature responses in an acute viral infection model are altered in interferon type I receptor-deficient mice.
Traynor TR; Majde JA; Bohnet SG; Krueger JM
Brain Behav Immun; 2006 May; 20(3):290-9. PubMed ID: 16243480
[TBL] [Abstract][Full Text] [Related]
18. Interferon-gamma, an anti-fibrogenic cytokine which binds to heparan sulfate.
Lortat-Jacob H; Esterre P; Grimaud JA
Pathol Res Pract; 1994 Oct; 190(9-10):920-2. PubMed ID: 7899141
[TBL] [Abstract][Full Text] [Related]
19. New insights into the evolution of IFNs: zebrafish group II IFNs induce a rapid and transient expression of IFN-dependent genes and display powerful antiviral activities.
López-Muñoz A; Roca FJ; Meseguer J; Mulero V
J Immunol; 2009 Mar; 182(6):3440-9. PubMed ID: 19265122
[TBL] [Abstract][Full Text] [Related]
20. The yin and yang of type I interferon activity in bacterial infection.
Decker T; Müller M; Stockinger S
Nat Rev Immunol; 2005 Sep; 5(9):675-87. PubMed ID: 16110316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
